• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症免疫编辑:整合免疫在癌症抑制和促进中的作用。

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion.

机构信息

Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.

出版信息

Science. 2011 Mar 25;331(6024):1565-70. doi: 10.1126/science.1203486.

DOI:10.1126/science.1203486
PMID:21436444
Abstract

Understanding how the immune system affects cancer development and progression has been one of the most challenging questions in immunology. Research over the past two decades has helped explain why the answer to this question has evaded us for so long. We now appreciate that the immune system plays a dual role in cancer: It can not only suppress tumor growth by destroying cancer cells or inhibiting their outgrowth but also promote tumor progression either by selecting for tumor cells that are more fit to survive in an immunocompetent host or by establishing conditions within the tumor microenvironment that facilitate tumor outgrowth. Here, we discuss a unifying conceptual framework called "cancer immunoediting," which integrates the immune system's dual host-protective and tumor-promoting roles.

摘要

了解免疫系统如何影响癌症的发生和发展一直是免疫学中最具挑战性的问题之一。过去二十年的研究有助于解释为什么这个问题长期以来一直困扰着我们。我们现在认识到,免疫系统在癌症中起着双重作用:它不仅可以通过破坏癌细胞或抑制其生长来抑制肿瘤生长,还可以通过选择更适合在免疫功能正常的宿主中生存的肿瘤细胞,或通过在肿瘤微环境中建立促进肿瘤生长的条件,来促进肿瘤的进展。在这里,我们讨论了一个被称为“癌症免疫编辑”的统一概念框架,该框架整合了免疫系统的双重宿主保护和肿瘤促进作用。

相似文献

1
Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion.癌症免疫编辑:整合免疫在癌症抑制和促进中的作用。
Science. 2011 Mar 25;331(6024):1565-70. doi: 10.1126/science.1203486.
2
Cancer immunoediting: from immunosurveillance to tumor escape.癌症免疫编辑:从免疫监视到肿瘤逃逸
Nat Immunol. 2002 Nov;3(11):991-8. doi: 10.1038/ni1102-991.
3
[The immune system - how does anti-tumor immunity arise ?].[免疫系统——抗肿瘤免疫是如何产生的?]
Oncol Res Treat. 2014;37 Suppl 4:2-5. doi: 10.1159/000366431. Epub 2014 Sep 30.
4
Cancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapy.癌症免疫编辑:抗原、机制及对癌症免疫治疗的启示。
Ann N Y Acad Sci. 2013 May;1284(1):1-5. doi: 10.1111/nyas.12105.
5
Commentary: Immune escape versus tumor tolerance: how do tumors evade immune surveillance?评论:免疫逃逸与肿瘤耐受:肿瘤如何逃避免疫监视?
Eur J Med Res. 2001 Aug 27;6(8):323-32.
6
The immune system--is it relevant to cancer development, progression and treatment?免疫系统——它与癌症的发生、发展及治疗有关吗?
Clin Oncol (R Coll Radiol). 2008 Mar;20(2):101-12. doi: 10.1016/j.clon.2007.10.011. Epub 2007 Nov 26.
7
Anti-tumor immunity: myeloid leukocytes control the immune landscape.抗肿瘤免疫:髓系白细胞控制免疫景观。
Cell Immunol. 2012 Jul-Aug;278(1-2):21-6. doi: 10.1016/j.cellimm.2012.06.014. Epub 2012 Jul 14.
8
Signaling defects in anti-tumor T cells.抗肿瘤T细胞中的信号缺陷。
Immunol Rev. 2008 Apr;222:192-205. doi: 10.1111/j.1600-065X.2008.00606.x.
9
Reverse immunoediting: When immunity is edited by antigen.反向免疫编辑:当免疫被抗原编辑时。
Immunol Lett. 2016 Jul;175:16-20. doi: 10.1016/j.imlet.2016.04.015. Epub 2016 Apr 27.
10
Tumor immunoediting and immunosculpting pathways to cancer progression.肿瘤免疫编辑和免疫塑造与癌症进展的途径。
Semin Cancer Biol. 2007 Aug;17(4):275-87. doi: 10.1016/j.semcancer.2007.06.009. Epub 2007 Jun 26.

引用本文的文献

1
Targeting necrotic lipid release in tumors enhances immunosurveillance and cancer immunotherapy of glioblastoma.靶向肿瘤中的坏死性脂质释放可增强胶质母细胞瘤的免疫监视和癌症免疫治疗。
Cell Res. 2025 Sep 3. doi: 10.1038/s41422-025-01155-y.
2
Value of a BRAF and lymphocyte subset-based nomogram for discriminating benign lesions from papillary thyroid carcinoma in C-TIRADS 3 and higher nodules.基于BRAF和淋巴细胞亚群的列线图在鉴别C-TIRADS 3类及以上结节中的甲状腺乳头状癌与良性病变方面的价值。
Front Endocrinol (Lausanne). 2025 Aug 15;16:1608222. doi: 10.3389/fendo.2025.1608222. eCollection 2025.
3
Coupled SDE-ODE Modeling of Tumor-Immune Dynamics to Infer Biomarker Release.
用于推断生物标志物释放的肿瘤-免疫动力学耦合随机微分方程-常微分方程建模
bioRxiv. 2025 Aug 21:2025.08.15.670571. doi: 10.1101/2025.08.15.670571.
4
Engineering strategies of sequential drug delivery systems for combination tumor immunotherapy.用于联合肿瘤免疫治疗的序贯给药系统的工程策略。
Acta Pharm Sin B. 2025 Aug;15(8):3951-3977. doi: 10.1016/j.apsb.2025.05.039. Epub 2025 Jun 6.
5
CAR Cell-Derived Exosomes in Cancer Therapy: Biogenesis, Engineering Strategies and Antitumor Mechanisms.嵌合抗原受体(CAR)细胞衍生外泌体在癌症治疗中的作用:生物发生、工程策略及抗肿瘤机制
Int J Mol Sci. 2025 Aug 15;26(16):7890. doi: 10.3390/ijms26167890.
6
Deciphering the mechanistic roles of ADARs in cancer pathogenesis, tumor immune evasion, and drug resistance.解读腺苷脱氨酶作用于RNA(ADARs)在癌症发病机制、肿瘤免疫逃逸和耐药性中的机制性作用。
Front Immunol. 2025 Aug 7;16:1621585. doi: 10.3389/fimmu.2025.1621585. eCollection 2025.
7
Unleashing NK cells for cancer immunotherapy in lung cancer: biologic challenges and clinical advances.释放自然杀伤细胞用于肺癌的癌症免疫治疗:生物学挑战与临床进展
J Exp Clin Cancer Res. 2025 Aug 23;44(1):251. doi: 10.1186/s13046-025-03503-7.
8
Recent Advancements in Immunotherapy for the Treatment of Metastatic Breast Cancer.转移性乳腺癌免疫治疗的最新进展
Cancer Treat Res. 2025;129:33-65. doi: 10.1007/978-3-031-97242-3_3.
9
Cancer Immunotherapy-An Overview.癌症免疫疗法——概述
Cancer Treat Res. 2025;129:1-16. doi: 10.1007/978-3-031-97242-3_1.
10
Evolutionary dynamics of recurrent hepatocellular carcinoma under divergent immune selection pressures.不同免疫选择压力下复发性肝细胞癌的进化动力学
Front Oncol. 2025 Aug 4;15:1537087. doi: 10.3389/fonc.2025.1537087. eCollection 2025.